Faron Pharmaceuticals OY (FARN) NPV
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
207.50p
211.00p
265.00p
£242.68 million
207.50p
200.00p
127.50p
n/a
0.00p (0.00%) Previous:
0.00p
1,334
n/a
750
Performance
| 1 week 1W | 3.49% | 1 year 1Y | 31.75% |
|---|---|---|---|
| 1 month 1M | 9.78% | 2 years 2Y | 17.98% |
| 3 months 3M | 17% | 3 years 3Y | 0% |
| 6 months 6M | 1.22% | 5 years 5Y | 30.83% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (€m) | n/a | n/a |
| Profit before tax (€m) | (25.91) | (30.94) |
| Adjusted EPS (¢): | (29.00) | (48.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Faron Pharmaceuticals appoints chief business officer
21 May 2025 14:31
-
Faron enters financing arrangement with Heights Capital Management entity
3 April 2025 10:28
-
Faron identifies final patient in BEXMAB phase two study
31 January 2025 11:29
-
FDA Grants Orphan Drug Designation
3 March 2025 12:05
-
Positive EMA Opinion on Orphan Drug Designation
27 February 2025 07:30
-
Annual Report 2024 published
27 February 2025 07:15
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.